topSkip to main content

Menu, Secondary

Menu Trigger


University of Southern California

The University of Southern California (USC) is one of the world’s leading private research universities. An anchor institution in Los Angeles, a global center for arts, technology and international business, USC’s diverse curricular offerings provide extensive opportunities for interdisciplinary study and collaboration with leading researchers in highly advanced learning environments.

Visit the university website.

New research co-authored by USC Price visiting scholar Dr. Jevay Grooms in the Journal of Substance Abuse Treatment shows that older Americans are increasingly seeking treatment for substance use disorder (SUD), and there are alarming racial disparities when it comes to completing treatment programs.
A USC study applies machine learning to identify significant behavioral triggers for escalating PTSD symptoms to develop preventive, just-in-time interventions. 
California voters support keeping daylight saving time throughout the year, but USC researchers say that might not be a good idea.
A new study by a USC-led team offers further confirmation that abnormalities in the GDF15 gene are involved in the development of hyperemesis gravidarum, and may provide insight into prediction and diagnosis of the disease.
Brain scans of children ages 9-10 with a binge eating disorder that causes uncontrollable overeating showed differences in gray matter density compared to their unaffected peers.
A new study from Keck Medicine of USC finds that the incidence rate of metastatic prostate cancer has significantly increased for men 45 and older and coincides with recommendations against routine prostate cancer screenings.
Results from a new study published today in Child Development provide the first longitudinal evidence about the trajectories of sensory reactivity patterns during early childhood among a large community sample with diverse developmental outcomes.
Experts at USC are using neural imaging to gain a deeper understanding of how sleep quality impacts the brain clearance process, a potential predictor of Alzheimer’s for the community at greatest risk for the disease.
Early in the COVID-19 pandemic, people hoped that the pandemic would end through ”herd immunity,” a scenario in which most people have antibodies from vaccination or prior infection and the virus slowly stops spreading because there are few new individuals to infect. 
Among older Americans surveyed in the weeks after FDA approval of aducanumab, few could correctly answer true or false questions about the first new Alzheimer’s drug in decades.